相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Immunogenomic landscape of gynecologic carcinosarcoma
Osamu Gotoh et al.
GYNECOLOGIC ONCOLOGY (2021)
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study
Kimberly K. Leslie et al.
GYNECOLOGIC ONCOLOGY (2021)
Racial disparities in survival among women with endometrial cancer in an equal access system
Amie B. Park et al.
GYNECOLOGIC ONCOLOGY (2021)
Victoria: A multicentric, randomized, open-label, phase I/II of mTOR inhibitor (VISTUSERTIB) combined with anastrozole in patients with hormone receptor-positive advanced/metastatic endometrial cancer-A CLIPP program INCA in collaboration with GINECO group.
Pierre-Etienne Heudel et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study
Pamela T. Soliman et al.
CLINICAL CANCER RESEARCH (2020)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Proteogenomic Characterization of Endometrial Carcinoma
Yongchao Dou et al.
CELL (2020)
Incorporation of molecular characteristics into endometrial cancer management
Lisa Vermij et al.
HISTOPATHOLOGY (2020)
Molecular variations in uterine carcinosarcomas identify therapeutic opportunities
Erin Crane et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley et al.
CANCER (2020)
Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity
Eli Awad et al.
GYNECOLOGIC ONCOLOGY (2020)
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Vicky Makker et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
Yohan Suryo Rahmanto et al.
NATURE COMMUNICATIONS (2020)
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis
Amanda N. Fader et al.
CLINICAL CANCER RESEARCH (2020)
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia Leon-Castillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER plus ) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
M. R. Mirza et al.
ANNALS OF ONCOLOGY (2020)
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
Anne Sophie V. M. van den Heerik et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
David S. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
The frequency of POLE-mutation in endometrial carcinoma and prognostic implications: a systemic review and meta-analysis
Alaa Salah Jumaah et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer
Nuran Sungu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study
Rhonda S. Arthur et al.
CANCER CAUSES & CONTROL (2019)
Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas
Tatiana Franceschi et al.
VIRCHOWS ARCHIV (2019)
The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis
N. A. J. Ryan et al.
GENETICS IN MEDICINE (2019)
The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication
Rosalba De Nola et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601).
Yoland Catherine Antill et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Imaging and Staging of Endometrial Cancer
S. C. Faria et al.
SEMINARS IN ULTRASOUND CT AND MRI (2019)
The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis
Lotfolah Saed et al.
BMC CANCER (2019)
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
Daniela Matei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma
Susanna Leskela et al.
CANCERS (2019)
TCGA molecular groups of endometrial cancer: Pooled data about prognosis
Antonio Raffone et al.
GYNECOLOGIC ONCOLOGY (2019)
Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
Ileana C. Cuevas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma
Osamu Gotoh et al.
NATURE COMMUNICATIONS (2019)
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
Marthe M. de Jonge et al.
CLINICAL CANCER RESEARCH (2019)
Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes
Jacqueline Feinberg et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2019)
Cancer susceptibility gene mutations in type I and II endometrial cancer
Beverly Long et al.
GYNECOLOGIC ONCOLOGY (2019)
Endocrine therapy in endometrial cancer: An old dog with new tricks
Katarzyna J. Jerzak et al.
GYNECOLOGIC ONCOLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme
Xuanxuan Xing et al.
NATURE COMMUNICATIONS (2019)
Sociodemographic disparities in stage-specific incidences of endometrial cancer: a registry-based study in West Sweden, 1995-2016
Teresia Svanvik et al.
ACTA ONCOLOGICA (2019)
Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas
Aysegul Sari et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Global, Regional, and National Burden of Endometrial Cancer, 1990-2017: Results From the Global Burden of Disease Study, 2017
Shuang Zhang et al.
FRONTIERS IN ONCOLOGY (2019)
Mutation Frequencies in Endometrial Cancer Patients of Different Ethnicities and Tumor Grades: An Analytical Study
Mohammad A. Althubiti
SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES (2019)
Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience
Maria Rubinstein et al.
GYNECOLOGIC ONCOLOGY REPORTS (2019)
Clinical actionability of molecular targets in endometrial cancer
Mary Ellen Urick et al.
NATURE REVIEWS CANCER (2019)
Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma
Aline Talhouk et al.
CLINICAL CANCER RESEARCH (2019)
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Pal Moller et al.
GUT (2018)
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
Navdeep Pal et al.
OBSTETRICS AND GYNECOLOGY (2018)
Endometrial cancer disparities: a race-conscious critique of the literature
Kemi M. Doll et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
S. Kommoss et al.
ANNALS OF ONCOLOGY (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
Carol Aghajanian et al.
GYNECOLOGIC ONCOLOGY (2018)
Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis
Xiao-san Zhang et al.
GYNECOLOGIC ONCOLOGY (2018)
Tumor associated macrophages in gynecologic cancers
Venkatesh Krishnan et al.
GYNECOLOGIC ONCOLOGY (2018)
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Amanda N. Fader et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2018)
Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas
Anne Mills et al.
MODERN PATHOLOGY (2018)
Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association
Grace Kim et al.
MODERN PATHOLOGY (2018)
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients
Karin Abbink et al.
TUMOR BIOLOGY (2018)
Uterine Microbiota: Residents, Tourists, or invaders?
James M. Baker et al.
FRONTIERS IN IMMUNOLOGY (2018)
The role of FDG-PET/CT in gynecologic imaging: an updated guide to interpretation and challenges
Esma A. Akin et al.
ABDOMINAL RADIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer Risks for PMS2-Associated Lynch Syndrome
Sanne W. ten Broeke et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women A Systematic Review and Meta-analysis
Megan A. Clarke et al.
JAMA INTERNAL MEDICINE (2018)
935PDPreliminary safety, efficacy, and PK/PD characterization from GARNET, a phase I clinical trial of the anti–PD-1 monoclonal antibody, TSR-042, in patients with recurrent or advanced MSI-H endometrial cancer
A Oaknin et al.
ANNALS OF ONCOLOGY (2018)
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
B. G. Wortman et al.
BRITISH JOURNAL OF CANCER (2018)
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
S. M. de Boer et al.
ANNALS OF ONCOLOGY (2018)
Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer
Amanda S. Bruegl et al.
CANCER PREVENTION RESEARCH (2017)
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome
Jaclyn C. Watkins et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2017)
Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis
Josee-Lyne Ethier et al.
GYNECOLOGIC ONCOLOGY (2017)
Intentional Weight Loss and Endometrial Cancer Risk
Juhua Luo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice
Yang Gao et al.
JOURNAL OF PATHOLOGY (2017)
Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium
Brian C. Willis et al.
MODERN PATHOLOGY (2017)
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
Katherine C. Kurnit et al.
MODERN PATHOLOGY (2017)
Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer
Koji Matsuo et al.
OBSTETRICS AND GYNECOLOGY (2017)
Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer
Seo Young Kang et al.
TRANSLATIONAL ONCOLOGY (2017)
The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and-9 in angiogenesis, metastasis, and prognosis of endometrial cancer
Anna M. Mahecha et al.
ONCOTARGETS AND THERAPY (2017)
Life after endometrial cancer: A systematic review of patient-reported outcomes
Robert Shisler et al.
GYNECOLOGIC ONCOLOGY (2017)
Juxtacrine Activity of Estrogen Receptor α in Uterine Stromal Cells is Necessary for Estrogen-Induced Epithelial Cell Proliferation
Wipawee Winuthayanon et al.
SCIENTIFIC REPORTS (2017)
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
Jeroen Depreeuw et al.
CLINICAL CANCER RESEARCH (2017)
Molecular mechanisms of hypoxia in cancer
Amarnath Challapalli et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Integrated Molecular Characterization of Uterine Carcinosarcoma
Andrew D. Cherniack et al.
CANCER CELL (2017)
American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review
Matthew M. Harkenrider et al.
BRACHYTHERAPY (2017)
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
Aline Talhouk et al.
CANCER (2017)
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
N. Colombo et al.
ANNALS OF ONCOLOGY (2016)
Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients
Alex Rabinovich
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Endometrial cancer: Not your grandmother's cancer
Jessica N. McAlpine et al.
CANCER (2016)
Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen
Chengcheng Ning et al.
CANCER RESEARCH (2016)
Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis
Melissa K. McConechy et al.
CLINICAL CANCER RESEARCH (2016)
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts
Ellen Stelloo et al.
CLINICAL CANCER RESEARCH (2016)
Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70 years of age
Anne Goverde et al.
GYNECOLOGIC ONCOLOGY (2016)
Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
Pamela T. Soliman et al.
GYNECOLOGIC ONCOLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor
Serkan Senol et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer
Douglas I. Lin et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2016)
Obesity and Cancer Mechanisms: Cancer Metabolism
Benjamin D. Hopkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
Fei Teng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2016)
Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort
Kari L. Ring et al.
MODERN PATHOLOGY (2016)
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
Inge C. Van Gool et al.
MODERN PATHOLOGY (2016)
Body Fatness and Cancer - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition
Siming Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Potential contribution of the uterine microbiome in the development of endometrial cancer
Marina R. S. Walther-Antonio et al.
GENOME MEDICINE (2016)
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations
Catherine A. Shu et al.
JAMA ONCOLOGY (2016)
Racial/Ethnic Disparities in Genomic Sequencing
Daniel E. Spratt et al.
JAMA ONCOLOGY (2016)
Disparities in Gynecological Malignancies
Sudeshna Chatterjee et al.
FRONTIERS IN ONCOLOGY (2016)
Foreign- vs US-born Asians and the association of type I uterine cancer
Elise Simons et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study
Shoji Nagao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women
Michele L. Cote et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER-Medicare Linked Database
Britton Trabert et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
Inge C. van Gool et al.
CLINICAL CANCER RESEARCH (2015)
Uterine carcinosarcoma: A review of the literature
Leigh A. Cantrell et al.
GYNECOLOGIC ONCOLOGY (2015)
European Society of Gynecological Oncology Task Force for Fertility Preservation Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients
Alexandros Rodolakis et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment
Christopher G. Pena et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Second-Line Therapy for Endometrial Cancer: The Need for Better Options
Gini F. Fleming
JOURNAL OF CLINICAL ONCOLOGY (2015)
Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer
Polly A. Newcomb et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The immune system in the normal endometrium and implications for endometrial cancer development
A. Vanderstraeten et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2015)
The Role of Robotic Surgery in Endometrial Cancer
David M. O'Malley et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
Ellen Stelloo et al.
MODERN PATHOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1
Brooke E. Howitt et al.
JAMA ONCOLOGY (2015)
Protective Effect of Bisphosphonates on Endometrial Cancer Incidence in Data From the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Sharon Hensley et al.
CANCER (2015)
Osteoporosis is less frequent in endometrial cancer survivors with hypertriglyceridemia
Akira Hirasawa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Adiposity and cancer risk: new mechanistic insights from epidemiology
Andrew G. Renehan et al.
NATURE REVIEWS CANCER (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device ± Metformin ± weight loss in endometrial cancer (feMME) trial
A. L. Hawkes et al.
CONTEMPORARY CLINICAL TRIALS (2014)
L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
T. Bosse et al.
EUROPEAN JOURNAL OF CANCER (2014)
Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: A meta-analysis
Seung-Hyuk Shim et al.
EUROPEAN JOURNAL OF CANCER (2014)
Serum HE4 as a prognostic marker in endometrial cancer - A population based study
Donal. J. Brennan et al.
GYNECOLOGIC ONCOLOGY (2014)
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies
Caiyun Liao et al.
GYNECOLOGIC ONCOLOGY (2014)
Endometrial cancer: A review and current management strategies: Part I
William M. Burke et al.
GYNECOLOGIC ONCOLOGY (2014)
The effect of bisphosphonates on the risk of endometrial and ovarian malignancies
Gad Rennert et al.
GYNECOLOGIC ONCOLOGY (2014)
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study
Gini F. Fleming et al.
GYNECOLOGIC ONCOLOGY (2014)
Histologic Effects of Medroxyprogesterone Acetate on Endometrioid Endometrial Adenocarcinoma: A Gynecologic Oncology Group Study
Richard J. Zaino et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2014)
Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma
Elisabetta Kuhn et al.
MODERN PATHOLOGY (2014)
Metabolic syndrome and endometrial cancer: a meta-analysis
Katherine Esposito et al.
ENDOCRINE (2014)
Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma
Sami K. Saarelainen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
C. Blake Gilks et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Diabetes mellitus and cancer risk: Review of the epidemiological evidence
Kentaro Shikata et al.
CANCER SCIENCE (2013)
Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States
B. Long et al.
GYNECOLOGIC ONCOLOGY (2013)
Etiologic heterogeneity in endometrial cancer: Evidence from a Gynecologic Oncology Group trial
Louise A. Brinton et al.
GYNECOLOGIC ONCOLOGY (2013)
The Role of Preexisting Diabetes Mellitus on Incidence and Mortality of Endometrial Cancer A Meta-Analysis of Prospective Cohort Studies
Zhi-Hua Zhang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Infiltration of Tumor-associated Macrophages is Increased in the Epithelial and Stromal Compartments of Endometrial Carcinomas
Erica C. Dun et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2013)
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Veronica Wendy Setiawan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Typical and atypical metastatic sites of recurrent endometrial carcinoma
Vikram Kurra et al.
CANCER IMAGING (2013)
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis
Ioannis D. Gallos et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
Michael Gnant et al.
CANCER TREATMENT REVIEWS (2012)
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Min-Han Tan et al.
CLINICAL CANCER RESEARCH (2012)
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
Han Liang et al.
GENOME RESEARCH (2012)
Cardiovascular disease is the leading cause of death among endometrial cancer patients
Kristy K. Ward et al.
GYNECOLOGIC ONCOLOGY (2012)
Tumor-Infiltrating Dendritic Cells May Be Used as Clinicopathologic Prognostic Factors in Endometrial Carcinoma
Zhao Lijun et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
Robert Coleman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Metabolic syndrome and endometrial cancer risk
V. Rosato et al.
ANNALS OF ONCOLOGY (2011)
Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug class
Philippe Clezardin
BONE (2011)
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E. Bignotti et al.
BRITISH JOURNAL OF CANCER (2011)
Stromal Deletion of the APC Tumor Suppressor in Mice Triggers Development of Endometrial Cancer
Pradeep S. Tanwar et al.
CANCER RESEARCH (2011)
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a Sandwich method for stage III, IV, and recurrent endometrial cancer
Melissa A. Geller et al.
GYNECOLOGIC ONCOLOGY (2011)
Immunofluorescence-Detected Infiltration of CD4+FOXP3+ Regulatory T Cells is Relevant to the Prognosis of Patients With Endometrial Cancer
Wataru Yamagami et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
FIFTEEN-YEAR RADIOTHERAPY OUTCOMES OF THE RANDOMIZED PORTEC-1 TRIAL FOR ENDOMETRIAL CARCINOMA
Carien L. Creutzberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Nonestrogenic Management of Hot Flashes
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding
Dong Ock Lee et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2011)
High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
Lydia W. T. Cheung et al.
CANCER DISCOVERY (2011)
Factors associated with Type I and Type II endometrial cancer
Ashley S. Felix et al.
CANCER CAUSES & CONTROL (2010)
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies
Thomas Hogberg et al.
EUROPEAN JOURNAL OF CANCER (2010)
Absolute Risk of Endometrial Carcinoma During 20-Year Follow-Up Among Women With Endometrial Hyperplasia
James V. Lacey et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Nonhormonal Management of Hot Flashes for Women on Risk Reduction Therapy
Kostandinos Sideras et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis
Yukiharu Todo et al.
LANCET (2010)
Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
Monika Janda et al.
LANCET ONCOLOGY (2010)
Hormone replacement after gynaecological cancer
Piksi Singh et al.
MATURITAS (2010)
Robotic-Assisted Hysterectomy for Endometrial Cancer Compared With Traditional Laparoscopic and Laparotomy Approaches A Systematic Review
Giorgia Gaia et al.
OBSTETRICS AND GYNECOLOGY (2010)
Diagnostic Strategies for Postmenopausal Bleeding
M. C. Breijer et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2010)
Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial Cancer A Controlled Randomized Study
Bengt Sorbe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2
Joan L. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Magnetic Resonance Imaging of Endometrial Carcinoma
Silanath Peungjesada et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2009)
Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma
Elke A. Jarboe et al.
MODERN PATHOLOGY (2009)
Efficacy of systematic pelvic endometrial cancer (MRC ASTEC trial): a randomised study
H. Kitchener et al.
LANCET (2009)
Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2009)
Racial disparities in recurrence among patients with early-stage endometrial cancer - Is recurrence increased in black patients who receive estrogen replacement therapy?
G. Larry Maxwell et al.
CANCER (2008)
Adjuvant Hormonal Therapy for Stage I Endometrial Cancer
Thomas K Oliver et al.
Current Oncology (2008)
What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
Nadeem R. Abu-Rustum et al.
GYNECOLOGIC ONCOLOGY (2008)
The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma
Jale Metindir et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
Pierluigi Benedetti Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis
N. Johnson et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Molecular and pathologic aspects of endometrial carcinogenesis
Jonathan L. Hecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study
Walter A. Rocca et al.
LANCET ONCOLOGY (2006)
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology
Christopher V. Lutman et al.
GYNECOLOGIC ONCOLOGY (2006)
Improved survival of Asians with corpus cancer compared with whites - An analysis of underlying factors
Mallory M. Zhang et al.
OBSTETRICS AND GYNECOLOGY (2006)
Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: A Gynecologic Oncology Group Study
RR Barakat et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study
ME Randall et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The molecular genetics and morphometry-based Endometrial Intraepithelial Neoplasia classification system predicts disease progression in Endometrial hyperplasia more accurately than the 1994 World Health Organization classification system
JP Baak et al.
CANCER (2005)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
BRCA germline mutations in Jewish women with uterine serous papillary carcinoma
O Lavie et al.
GYNECOLOGIC ONCOLOGY (2004)
Endometrial cancer: Socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival
T Madison et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2004)
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study
JV Fiorica et al.
GYNECOLOGIC ONCOLOGY (2004)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Stromal cells can contribute oncogenic signals
TD Tlsty
SEMINARS IN CANCER BIOLOGY (2001)
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R Goshen et al.
GYNECOLOGIC ONCOLOGY (2000)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
分享论文
